Addex Pharmaceuticals
Officials from Addex Pharmaceuticals report on recent developments
Published in Lab Business Week, February 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Addex Pharmaceuticals.
Report 1: Addex Pharmaceuticals announced the start of a phase IIa proof of concept study on lead compound ADX10059 in patients with moderately severe dental anxiety. This is the third indication in a phase IIa development program in which ADX10059 is also being evaluated for acute treatment of migraine and for prevention of acid reflux in patients with gastroesophageal reflux disease (GERD).
The latter two studies are being conducted in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-02-25)
More Articles from Lab Business Week
- Biochemistry
Study data from Chester Beatty Laboratories update knowledge of biochemistry - Biotechnology
PRL Central Laboratory Services announces regional agreement with Kansas organization - Business Update
Brian Tambi opens BrianT Laboratories in Lake Forest, Illinois - Business Update
Lawrence Berkeley National Laboratory issues long-range development plan - Business Update
Stiefel Laboratories receives U.S. FDA approval of Olux-E foam, 0.05% for psoriasis, eczema - Epidemiology
Investigators at Channing Laboratory have published new data on epidemiology - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
